Merck & Co. Total Current Assets decreased by 8.5% to $43.52B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.2%, from $38.78B to $43.52B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 9.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
A higher value relative to current liabilities indicates a strong safety margin for meeting short-term obligations.
The sum of all assets that are reasonably expected to be converted into cash or consumed within one year. This aggregate...
High-growth tech companies often maintain high current asset levels to support rapid scaling and R&D needs.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.67B | $31.06B | $30.27B | $31.18B | $32.12B | $33.56B | $35.72B | $33.40B | $29.98B | $31.95B | $32.17B | $31.45B | $38.21B | $40.36B | $38.78B | $35.50B | $37.07B | $47.56B | $43.52B |
| QoQ Change | — | +8.3% | -2.6% | +3.0% | +3.0% | +4.5% | +6.4% | -6.5% | -10.3% | +6.6% | +0.7% | -2.2% | +21.5% | +5.6% | -3.9% | -8.5% | +4.4% | +28.3% | -8.5% |
| YoY Change | — | — | — | — | +12.0% | +8.1% | +18.0% | +7.1% | -6.7% | -4.8% | -9.9% | -5.9% | +27.4% | +26.3% | +20.6% | +12.9% | -3.0% | +17.8% | +12.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.